Here’s how analysts see Option Care Health, Inc. (NASDAQ:BIOS) after this past week.

Option Care Health, Inc. (NASDAQ:BIOS) Logo
Investors sentiment increased to 1.02 in Q2 2019. Its up 0.02, from 1 in 2019Q1. It increased, as 14 investors sold Option Care Health, Inc. shares while 29 reduced holdings. 16 funds opened positions while 28 raised stakes. 96.75 million shares or 0.75% less from 97.49 million shares in 2019Q1 were reported.
Dimensional Fund Advsrs Lp holds 0% or 2.55M shares. State Bank Of America De accumulated 51,778 shares. Clarivest Asset Mngmt Limited reported 0.01% stake. Moreover, State Board Of Administration Of Florida Retirement has 0% invested in Option Care Health, Inc. (NASDAQ:BIOS). Jane Street Lc has invested 0% in Option Care Health, Inc. (NASDAQ:BIOS). Charles Schwab Management Incorporated has invested 0% in Option Care Health, Inc. (NASDAQ:BIOS). Federated Pa reported 3,984 shares stake. California Employees Retirement System, California-based fund reported 320,565 shares. M&T Financial Bank holds 0% or 80,000 shares in its portfolio. 761,957 are held by Wells Fargo And Com Mn. Moreover, Engineers Gate Manager Lp has 0.01% invested in Option Care Health, Inc. (NASDAQ:BIOS). Deutsche Comml Bank Ag, Germany-based fund reported 4.12 million shares. Aperio Group Ltd stated it has 0% in Option Care Health, Inc. (NASDAQ:BIOS). Ameritas Invest Prtn owns 9,711 shares. Fmr Ltd Liability owns 3.94M shares.

Option Care Health, Inc. (NASDAQ:BIOS) Ratings Coverage

Among 3 analysts covering BioScrip (NASDAQ:BIOS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip has $4 highest and $3.5 lowest target. $3.83’s average target is 8.50% above currents $3.53 stock price. BioScrip had 6 analyst reports since March 18, 2019 according to SRatingsIntel. The rating was maintained by Barrington on Monday, March 18 with “Buy”. Canaccord Genuity maintained Option Care Health, Inc. (NASDAQ:BIOS) rating on Thursday, August 8. Canaccord Genuity has “Buy” rating and $400 target. Canaccord Genuity maintained it with “Buy” rating and $3.5 target in Monday, March 18 report. The stock has “Buy” rating by Lake Street on Monday, March 18. Below is a list of Option Care Health, Inc. (NASDAQ:BIOS) latest ratings and price target changes.

08/08/2019 Broker: Canaccord Genuity Rating: Buy Old Target: $3.5000 New Target: $4.0000 Maintain
11/05/2019 Broker: BidaskScore Rating: Hold Upgrade
18/03/2019 Broker: Lake Street Rating: Buy New Target: $3.5 Maintain
18/03/2019 Broker: Canaccord Genuity Rating: Buy New Target: $3.5 Maintain
18/03/2019 Broker: Barrington Rating: Buy New Target: $4 Maintain
18/03/2019 Broker: Stephens Old Rating: Overweight New Rating: Equal-Weight Downgrade

The stock increased 3.52% or $0.12 during the last trading session, reaching $3.53. About 1.85M shares traded or 90.81% up from the average. Option Care Health, Inc. (NASDAQ:BIOS) has risen 2.17% since September 13, 2018 and is uptrending. It has outperformed by 2.17% the S&P500.

BioScrip, Inc. provides home infusion services in the United States. The company has market cap of $2.48 billion. The firm engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It currently has negative earnings. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care.

More notable recent Option Care Health, Inc. (NASDAQ:BIOS) news were published by: Globenewswire.com which released: “BioScrip, Inc. Provides Merger Update Nasdaq:BIOS – GlobeNewswire” on April 23, 2019, also Seekingalpha.com with their article: “BioScrip shareholders back Option Care merger – Seeking Alpha” published on August 02, 2019, Globenewswire.com published: “BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call – GlobeNewswire” on March 13, 2019. More interesting news about Option Care Health, Inc. (NASDAQ:BIOS) were released by: Marketwatch.com and their article: “S&P 500, Nasdaq close at 5-month high on China trade, global growth optimism – MarketWatch” published on March 15, 2019 as well as Seekingalpha.com‘s news article titled: “BioScrip, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” with publication date: March 15, 2019.

Option Care Health, Inc. (NASDAQ:BIOS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.